Search articles in Pharma Appointments

Found 854 articles

  • Alnylam Pharmaceuticals appoints Phil Davey as Cou

    Alnylam Pharmaceuticals appoints Phil Davey as Country Manager, UK & Ireland

    • 25 May 2022
    • Editor

    Alnylam Pharmaceuticals has announced the appointment of Phil Davey as Country Manager of the UK and Ireland. Commenting on his appointment, Phil said: "I am delighted to have joined Alnylam as Country Manager for the UK and Ireland.

  • Beckley Psytech strengthens senior leadership team

    Beckley Psytech strengthens senior leadership team with appointment of Dr. Laura Trespidi as Chief Development Officer

    • 25 May 2022
    • Editor

    Beckley Psytech, a private company dedicated to addressing neurological and psychiatric disorders through the novel application of psychedelic medicines, has today announced the appointment of Dr. Laura Trespidi as Chief Development Officer.

  • Siggi Olafsson to step down as Chief Executive

    Siggi Olafsson to step down as Chief Executive

    • 24 May 2022
    • Editor

    Hikma Pharmaceuticals PLC (Hikma) today announces that Siggi Olafsson has resigned as Chief Executive Officer (CEO), and from Hikma’s Board of Directors, to pursue other opportunities.

  • Nouscom Announces Promotion of Richard Davis to Ch

    Nouscom Announces Promotion of Richard Davis to Chief Operating Officer

    • 24 May 2022
    • Editor

    Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vectored immunotherapies, today announced the promotion of Richard (Rick) Davis, PhD to Chief Operating Officer (COO) effective immediately. Rick joined Nouscom in September 2020 as Chief Business Officer.

  • Immutep appoints leading oncologists to its Clinic

    Immutep appoints leading oncologists to its Clinical Advisory Board

    • 19 May 2022
    • Editor

    Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep" or "the Company"), a biotechnology company developing novel LAG-3 related immunotherapy treatments for cancer and autoimmune diseases, announces today the appointment of four new members to the Company's Clinical Advisory Board (CAB).

  • Coulter Partners announces two additional appointm

    Coulter Partners announces two additional appointments in Italy

    • 16 May 2022
    • Editor

    Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, announces two additional appointments to its new Milan office.

  • SciRhom Announces Addition to the Management Team

    SciRhom Announces Addition to the Management Team

    • 13 May 2022
    • Editor

    To optimize management expertise for the next phase of development, Dr. Jan Poth will assume the role of Chief Executive Officer in advancing the company’s proprietary anti-iRhom2 antibodies.

  • Richard Park appointed to Global Head of Client Re

    Richard Park appointed to Global Head of Client Relations & Business Development

    • 13 May 2022
    • Editor

    evitria AG, a Zurich, Switzerland-based contract research, development, and manufacturing organization focused on transient recombinant antibody and protein production, announced that former Director of Client Relations, Richard Park, has been appointed Global Head of Client Relations and Business Development.

  • Coulter Partners expands its global team with key

    Coulter Partners expands its global team with key appointments and a new office in Italy

    • 13 May 2022
    • Editor

    Coulter Partners, the global experts in Executive Search and Leadership Development in Life Sciences, Health and Tech, announces the opening of its new office in Milan and two additional key appointments. Francesca Lazzarin joins as Executive Director and Giuliana Milioto as Research Associate. We will be announcing two further appointments next week.

  • Ian Adamson Joins Maxwellia as Strategic Advisor

    Ian Adamson Joins Maxwellia as Strategic Advisor

    • 12 May 2022
    • Editor

    Maxwellia’s pioneering vision, exponential growth, and media grabbing headlines over the past two years has attracted industry expert Ian Adamson who joins the company as strategic advisor. Ian’s role will be to work with Maxwellia to shape the next phase of pharmacy medicine launches - a process which involves identifying and converting suitable prescription only medicines into versions people can choose to buy under the supervision of a pharmacist.

  • Johnson & Johnson Appoints Thibaut Mongon as CEO D

    Johnson & Johnson Appoints Thibaut Mongon as CEO Designate of Planned New Consumer Health Company

    • 12 May 2022
    • Editor

    Johnson & Johnson (the “Company”) (NYSE: JNJ) today announced the appointment of Thibaut Mongon as Chief Executive Officer Designate and Paul Ruh as Chief Financial Officer Designate of the future, listed New Consumer Health Company.

  • finnCap appoints Dr Stephen McGarry to strengthen

    finnCap appoints Dr Stephen McGarry to strengthen Life Sciences team

    • 12 May 2022
    • Editor

    finnCap Group is delighted to announce the appointment of Dr. Stephen McGarry as Research Director in its Life Sciences team. Stephen is joining the research team to expand the growth trajectory of the franchise following its strong performance over the last two years.

  • Rejuvenate Biomed appoints life sciences leader Dr

    Rejuvenate Biomed appoints life sciences leader Dr. Ajit Shetty as Chair of the Board of Directors to help guide international ambitions

    • 12 May 2022
    • Editor

    Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, appoints Dr. Ajit Shetty as Chair of the Board of Directors. As a veteran of the life sciences industry, Dr. Shetty will strengthen the business strategy of this ambitious company through both mentorship and connections.

  • SOLVE FSHD Announces Appointment of Executive Dire

    SOLVE FSHD Announces Appointment of Executive Director Dr. Eva Chin and Venture-Philanthropic Funding Structure

    • 12 May 2022
    • Editor

    Following SOLVE FSHD’s recent acclaimed launch, the organization is pleased to formally announce the appointment of Dr. Eva Chin as the Executive Director. SOLVE FSHD’s Founder, Chip Wilson, has personally committed USD100 million to find a cure for facioscapulohumeral muscular dystrophy (FSHD), a rare disease he was diagnosed with at the age of 32.

  • Evaluate appoints Matthew Wright as Chief Financia

    Evaluate appoints Matthew Wright as Chief Financial Officer

    • 11 May 2022
    • Editor

    Evaluate, a leading provider of market intelligence and predictive analytics for the pharmaceutical industry, has today announced that it has appointed Matthew Wright as Chief Financial Officer.

  • DNA Script Appoints Chris Barbazette as Chief Comm

    DNA Script Appoints Chris Barbazette as Chief Commercial Officer

    • 10 May 2022
    • Editor

    DNA Script, a world leader in Enzymatic DNA Synthesis (EDS) for DNA on demand, has added life sciences veteran Chris Barbazette as Chief Commercial Officer to its leadership team. In his new position, Barbazette will be responsible for leading DNA Script’s marketing, sales, and support teams and will play a pivotal role in building upon the company’s market position to drive continued commercial growth, as well as investor and customer value.

  • Pneumagen Announces Appointment of John Beadle as

    Pneumagen Announces Appointment of John Beadle as Non-Executive Director

    • 10 May 2022
    • Editor

    Pneumagen, a clinical stage biotech company developing Neumifil, a novel intranasal spray which is designed to provide patients at risk with an easy to use, pan-anti-viral treatment to reduce, prevent and manage respiratory disease exacerbations caused by viral infections, announces the appointment of Dr. John Beadle, Founder and former Chief Executive Officer of PsiOxus Therapeutics Ltd, as a Non-Executive director of the company.

  • Augustine Therapeutics appoints Gerhard Koenig as

    Augustine Therapeutics appoints Gerhard Koenig as Chairman of the Board, forms Clinical Advisory Board, and broadens therapeutic indications.

    • 10 May 2022
    • Editor

    Augustine Therapeutics, a biotech company developing novel therapies for neuromuscular and neurodegenerative disorders, appoints Gerhard Koenig as Chairman of the Board. The company also expands the Scientific Advisory Board with clinical experts to support broader therapeutic applications, exploring the potential of novel HDAC6 inhibitors in Charcot-Marie-Tooth disease (CMT).

  • LUMICKS Appoints Andre Nel as Chief Financial Offi

    LUMICKS Appoints Andre Nel as Chief Financial Officer

    • 10 May 2022
    • Editor

    LUMICKS, a leading life science tools company that develops instruments for dynamic single-molecule and cell avidity analysis, today announced that Andre Nel has been appointed Chief Financial Officer. He will be based in the Company’s headquarters in Amsterdam.

  • Mary Lynne Hedley Elected to Lilly Board of Direct

    Mary Lynne Hedley Elected to Lilly Board of Directors

    • 9 May 2022
    • Editor

    The Board of Directors of Eli Lilly and Company (NYSE:LLY) has elected Mary Lynne Hedley, Ph.D., as a new member, effective May 15, 2022. As a member of Lilly's board, she will serve on both the Science & Technology Committee and the Ethics and Compliance Committee.